Skip to content
Recall Observatory FDA recall evidence

Drug product

Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.

D-1094-2023

August 10, 2023

Class III

Product summary

Firm
Imprimis NJOF, LLC
Event
Event 92848
Status
Terminated
Classification
Class III
Quantity
2,683 bottles
Official record key
drug-enforcement:D-1094-2023

Official wording

Reason: Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

Code information: Lot #s: 22DEC047 exp 9/16/23, 23FEB057 exp 11/24/23.

Distribution pattern: Nationwide in the US

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent

Field note

Send feedback

We'll only use this to respond to your feedback.